Liraglutide Treatment Is Associated with a Low Frequency and Magnitude of Antibody Formation with No Apparent Impact on Glycemic Response or Increased Frequency of Adverse Events: Results from the Liraglutide Effect and Action in Diabetes (LEAD) trials
John B Buse, Alan Garber, Julio Rosenstock, Wolfgang E Schmidt, Jason H Brett, Nicoline Videbæk, Jens Juul Holst, Michael Nauck
98Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Liraglutide Treatment Is Associated with a Low Frequency and Magnitude of Antibody Formation with No Apparent Impact on Glycemic Response or Increased Frequency of Adverse Events: Results from the Liraglutide Effect and Action in Diabetes (LEAD) trials'. Together they form a unique fingerprint.